COMPASS Pathways
CMPS
#6948
Rank
C$0.78 B
Marketcap
C$8.16
Share price
3.88%
Change (1 day)
40.13%
Change (1 year)

P/E ratio for COMPASS Pathways (CMPS)

P/E ratio as of December 2025 (TTM): -2.14

According to COMPASS Pathways's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.14366. At the end of 2024 the company had a P/E ratio of -1.64.

P/E ratio history for COMPASS Pathways from 2020 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-1.64
2022-3.72-70.06%
2021-12.4-29.82%
2020-17.7

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
ORIC Pharmaceuticals
ORIC
-6.52 204.30%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.